Skip to content

Effectiveness of hospital-based case management intervention on Chinese colorectal cancer patients

Effectiveness of hospital-based case management intervention on Chinese colorectal cancer patients - Effectiveness of hospital-based case management intervention on Chinese colorectal cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044887
Enrollment
156
Registered
2021-07-17
Start date
2015-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

intervention group was managed for one year by case manager, who organized multidisciplinary team, provided regular assessment, consulting service, and referrals. routine care

Sponsors

Department of Finance of Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnosed with colorectal cancer through histopathology; (2) Aged between 18 and 65 years old; (3) Treated for the first time and accepted adjuvant chemotherapy; (4) Patients with an expected survival time >1 year; (5) willing to participate with informed consent.

Exclusion criteria

Exclusion criteria: (1) patients without the ability of reading, writing and understanding of Chinese; (2) Patients with metastasis or recurrence; (3) Diagnosed with an advanced stage of cancer and accepted palliative therapy; (4) Patients with severe cardiopulmonary function disorders, such as heart function level 3 and above, COPD, level 3 hypertension; (5) Patients with psychiatric history.

Design outcomes

Primary

MeasureTime frame
quality of life was measured at baseline (T0), three days after operation (T1), the first stage (T2-1), middle stage (T2-2) and last stage of chemotherapy (T2-3), and the end of one-year intervention (T3).

Secondary

MeasureTime frame
Anxiety and depression and symptom distress are measured at six time points same as quality of life. Overall treatment adherence was calculated at the end of T3. Oral chemotherapy adherence was measured at T2-1, T2-2 and T2-3 of chemotherapy. Unplanned readmission rates were measured at the end of T1, T2 and T3.

Countries

Asia(except Japan)

Contacts

Public ContactMeifen Zhang

Sun Yat-sen University School of Nursing

zhmfen@mail.sysu.edu.cn(+86)13416225022

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026